Keyphrases
Hormone Receptor-positive
100%
Node-positive
100%
21-gene Recurrence Score
100%
Cautionary Tales
100%
Recurrence Score
100%
HER2-negative Breast Cancer
100%
Chemotherapy
71%
Adjuvant Chemotherapy
42%
5-year Survival
42%
Subgroup Analysis
28%
Human Epidermal Growth Factor Receptor 2 (HER2)
28%
Tumor
14%
Multivariate Analysis
14%
Breast Cancer Patients
14%
Young Age
14%
Large Tumors
14%
Positive Lymph Nodes
14%
Axillary Lymph Node Dissection
14%
Survival Benefit
14%
Univariate Analysis
14%
Mastectomy
14%
National Cancer Database
14%
Retrospective Data
14%
21-gene Recurrence Score Assay
14%
Node-positive Breast Cancer
14%
HER2 Breast Cancer
14%
Adjuvant Chemotherapy Benefit
14%
HER2-positive
14%
Medicine and Dentistry
Breast Cancer
100%
Recurrent Disease
100%
Hormone Receptor
100%
Chemotherapy
55%
Adjuvant Chemotherapy
44%
Neoplasm
22%
Subgroup Analysis
22%
Malignant Neoplasm
11%
Clinician
11%
Lymph Node
11%
Multivariate Analysis
11%
Axillary Lymph Node
11%
Retroperitoneal Lymph Node Dissection
11%
Univariate Analysis
11%
Mastectomy
11%
Lymph Node Irradiation
11%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
11%